Emerald Health Therapeutics Inc TBQBF

RE:RE:Northern Vine

[HaulJockey]

Nastysasky wrote: It's actually Abattis that has the rights to sell/use the extraction tech. Northern Vine is a subsiderary of Abattis and Emerald (47% & 53% respectively).

I think of this tech and its deployment as a service versus an asset. Think of a photocopier and Kinkos in the early days. You could buy a big expensive photocopier/extractor or simply farm out all that work to Kiinkos/Abattis and expense it in COGS vs having assets and depreciation.

The individual business model will dictate the usage of these machines. 

Te tests were performed at Northern Vines because NV has the licenses to allow for such testing.



Thanks for the info. I'm cautious though about farming out the work to ATT. If the role was reversed and Aph had a deal with NV instead of EMH, would EMH want APH to have access to pre market data on their product? So I'm thinking purchase instead?